Sulfadoxine-Pyrimethamine/Chloroquine

DRUG2 trials

Sponsors

Pfizer

Conditions

Malaria, FalciparumPLASMODIUM FALCIPARUM MALARIA

Phase 2

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

CompletedNCT00074841

PfizerPLASMODIUM FALCIPARUM MALARIA

Start: 2003-09-30End: 2005-01-31Updated: 2011-05-10

Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

TerminatedNCT00084240

PfizerMalaria, Falciparum

Start: 2004-03-31End: 2005-04-30Updated: 2008-11-03